期刊文献+

过氧苯甲酰凝胶的研制和体外评价

Preparation and in vitro Evaluation of Benzoyl Peroxide Gel
原文传递
导出
摘要 制备了一种过氧苯甲酰凝胶,并与原研制剂进行体外等效性评价。采用琼脂凝胶扩散法测定凝胶中药物的扩散系数(K),并以此为指标用单因素试验筛选出自制凝胶的处方组成。所得优化处方中采用d(0.9)为5.86μm过氧苯甲酰原料药,含泊洛沙姆407 0.3%,卡波姆980 1.5%。根据过氧苯甲酰在不同介质中的饱和溶解度结果筛选接收介质。以市售凝胶剂班赛~?为对照,比较自制凝胶与原研制剂体外释放曲线的相似性,结果显示二者一致性良好(相似因子为72)。以猪皮为屏障进行体外透皮释放试验,HPLC法测定接收液、皮肤表面和皮肤层内过氧苯甲酰浓度,以及皮肤内的苯甲酸浓度。结果显示,自制凝胶与原研制剂中绝大部分药物都滞留在皮肤表面,皮肤中均检出少量过氧苯甲酸和苯甲酸。自制凝胶和市售凝胶的体外释放行为和体外透皮释放特性相似,提示自制凝胶在体外具有相同的有效性。 The aim of the present work was to develop a benzoyl peroxide(BPO)(5%) gel for skin acne vulgaris treatment, and the evaluation of in vitro equivalance to the reference listed drug(RLD), Benzihex AC, was carried out. The formulations of the gel were formulated by employing Carbopol 980 as hydrophilic matrix and poloxamer 407 as sorbefacient. Optimization of formulation was supported by agar diffusion method and the following factors were investigated through single factor screening at three levels: the partical size of BPO(100-400 mesh number), the concentration of Carbopol 980(1.0%-2.0%) and poloxamer 407(0.1%-0.3%). The response variables was the diffusion distance in agar. The optimized gel had similar in vitro release profiles to the RLD based on the similarity factor(f2). The delivery amounts of BPO into and through the pig skin from the optimized gel were compared to those from RLD. Both gels showed consistent behavior: the stratum corneum uptake and skin penetration of BPO from the two gels were generally comparable. Taken together, the results of this research provided a generic BPO gel that was in vitro equivalent to the RLD.
作者 史家骏 马晋隆 沈琦 徐驿 黄乐乐 SHI Jiajun;MA Jinlong;SHEN Qi;xu Yi;HUANG Lele(Shanghai Jiaotong University, Shanghai 200240;National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2018年第6期760-766,共7页 Chinese Journal of Pharmaceuticals
关键词 过氧苯甲酰 凝胶 处方筛选 琼脂凝胶扩散法 体外释放 体外透皮释放 benzoyl peroxide gel formulation screening agar diffusion method in vitro release in vitro skin permeation
  • 相关文献

参考文献5

二级参考文献49

  • 1吴艳,毛越苹,郑捷,彭振辉,陈兴平,杨功焕,曾凡钦,徐慧珍,肖生祥,江文,马杰民,朱学骏.寻常痤疮对患者心理的影响[J].中国麻风皮肤病杂志,2004,20(6):536-538. 被引量:47
  • 2朱文元.痤疮的局部治疗[J].临床皮肤科杂志,1993,22(A60):33-34. 被引量:5
  • 3孙珍秀.大学生痤疮发病率调查分析[J].中国麻风皮肤病杂志,2005,21(12):994-995. 被引量:7
  • 4Duggan ST, Curran MP. Transdermal granisetron [J]. Drugs, 2009, 69 (18): 2597-2605.
  • 5Tuca A. Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review[J]. Cancer Manag Res, 2009, 2 (1) : 1-12.
  • 6Farlow MR, Alva G, Meng X, et al. A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis[J]. Curt Med Res Opin, 2010, 26 (2) : 263-269.
  • 7Plosker GL. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non- malignant pain [J]. Drugs, 2011, 71 (18) : 2491-2509.
  • 8Steiner D J, Sitar S, Wen W, et al. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naive patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study[ J]. J Pain Symptom Manage, 2011, 42 (6) : 903-917.
  • 9Watson Pharma. ANDRODERM (testosterone transdermal system), for topical use [EB/OL]. http://www.accessdata.fda. gov/drugsatfda_docs/label/2012/020489s0271bl.pdf.
  • 10Senesh G, Bushi D, Neta A, et al. Compatibility of insulin Lispro, Aspart, and Glulisine with the Solo MicroPump, a novel miniature insulin pump [J]. J Diabetes Sci Technol, 2010,4(1): 104-110.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部